Back to Search
Start Over
Improving the coverage and accuracy of syphilis testing: The development of a novel rapid, point-of-care test for confirmatory testing of active syphilis infection and its early evaluation in China and South Africa
- Source :
- EClinicalMedicine, Vol 24, Iss, Pp 100440-(2020), EClinicalMedicine, ECLINICAL MEDICINE
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Background Current point-of-care tests (POCT) for syphilis, based on the detection of Treponema pallidum (TP) total antibodies, have limited capacity in distinguishing between active and past/treated syphilis. We report the development and early evaluation of a new prototype POCT based on the detection of TP-IgA antibodies, a novel biomarker for active syphilis. Methods The TP-IgA POCT (index test) was developed in response to the World Health Organisation (WHO) target product profile (TPP) for a POCT for confirmatory syphilis testing. Two sub-studies were conducted consecutively using 458 pre-characterised stored plasma samples in China (sub-study one, addressing the criteria for the WHO TPP), and 503 venous blood samples collected from pregnant/postpartum women in South Africa (sub-study two, addressing potential clinical utility). Performance of the index test was assessed against standard laboratory-based serology using a combination of treponemal (TPHA) and non-treponemal (rapid plasma reagin [RPR]) tests. Findings In sub-study one, the index test demonstrated 96·1% (95%CI=91·7%-98·5%) sensitivity and 84·7% (95%CI=80·15–88·6%) specificity for identification of active syphilis (TPHA positive, RPR positive). It correctly identified 71% (107/150) samples of past-treated syphilis (TPHA positive, RPR negative). In sub-study two, the index test achieved 100% (95%CI=59%-100%) sensitivity for active syphilis and correctly identified all nine women with past syphilis. Interpretation The TP-IgA POCT has met the WHO TPP for a POCT for diagnosis of active syphilis and demonstrated its potential utility in a clinical setting. Future studies are warranted to evaluate field performance of the final manufactured test. Funding Saving Lives at Birth: Grand Challenge for Development, Thrasher Research Fund, and the Victorian Government Operational Infrastructure Scheme.
- Subjects :
- China
medicine.medical_specialty
Research paper
Point-of-care testing
Syphilis infection
Diagnostic accuracy
01 natural sciences
Rapid plasma reagin
World health
Serology
South Africa
03 medical and health sciences
0302 clinical medicine
Syphilis testing
Medicine and Health Sciences
Medicine
Syphilis
030212 general & internal medicine
Point of care test
0101 mathematics
lcsh:R5-920
Treponema
medicine.diagnostic_test
biology
business.industry
Obstetrics
010102 general mathematics
General Medicine
biology.organism_classification
medicine.disease
lcsh:Medicine (General)
business
IgA
Subjects
Details
- ISSN :
- 25895370
- Volume :
- 24
- Database :
- OpenAIRE
- Journal :
- eClinicalMedicine
- Accession number :
- edsair.doi.dedup.....e3f08e36cc8a850f3cd5664d84a1edf2
- Full Text :
- https://doi.org/10.1016/j.eclinm.2020.100440